Merck | Merck | Virginia | state | 2019 | $1,300,000 | | grant |
Taro Pharmaceuticals U.S.A., Inc. | Sun Pharmaceuticals | New Jersey | state | 2003 | $1,287,195 | | grant |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2008 | $1,274,849 | | enterprise zone |
MALLINCKRODT MEDICAL, INC. | Mallinckrodt | Missouri | state | 2001 | $1,274,667 | | tax credit/rebate |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,271,658 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2015 | $1,264,635 | | tax credit/rebate |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Hi-Tech Pharmacal, Inc. | Akorn Inc. | New York | state | 2014 | $1,257,792 | | enterprise zone |
Pfizer Inc. | Pfizer | Pennsylvania | state | 2008 | $1,257,546 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2006 | $1,250,000 | | tax credit/rebate |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2010 | $1,250,000 | | tax credit/rebate |
Sigma-Aldrich Corporation | Merck KGaA (EMD) | Wisconsin | state | 2017 | $1,250,000 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2013 | $1,230,023 | | tax credit/rebate |
Foundation Medicine | Roche | Massachusetts | state | 2014 | $1,225,860 | | tax credit/rebate |
ARIAD Pharmaceuticals, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $1,225,000 | | tax credit/rebate |
DePuy Othopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2012 | $1,224,300 | | tax credit/rebate |
Momenta Pharmaceuticals, Inc | Johnson & Johnson | Massachusetts | state | 2012 | $1,224,300 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $1,223,167 | | tax credit/rebate |
Abbott Point of Care Inc. and Abbott Diabetes Care | Abbott Laboratories | New Jersey | state | 2008 | $1,218,244 | | grant |
Eisai, Inc. and Eisai Corporation of North America | Eisai | New Jersey | state | 2005 | $1,203,750 | | grant |
Easel Biotechnologies, LLC | Bristol-Myers Squibb | United States | federal | 2014 | $1,201,621 | | federal grant |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2016 | $1,201,228 | | training reimbursement |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | | $1,200,000 | | tax credit/rebate |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $1,200,000 | | grant |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | $1,200,000 | | grant |
Novitas Solutions, Inc. | Novartis | Florida | state | 2013 | $1,200,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2017 | $1,200,000 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2011 | $1,196,763 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2015 | $1,192,386 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2008 | $1,187,088 | | enterprise zone |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $1,170,852 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2009 | $1,169,891 | | enterprise zone |
Astellas US LLC | Astellas Pharma | United States | federal | 2013 | $1,160,482 | | federal grant |
Vertex Pharmaceuticals, Inc | Vertex Pharmaceuticals | Massachusetts | state | 2011 | $1,152,515 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2008 | $1,152,412 | | enterprise zone |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2015 | $1,150,515 | | tax credit/rebate |
Janssen Biotech Inc | Johnson & Johnson | Pennsylvania | state | 2021 | $1,148,700 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2014 | $1,144,884 | | tax credit/rebate |
Novartis #1 | Novartis | New Jersey | state | 2005 | $1,142,400 | | Tax credit/rebate |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2004 | $1,130,588 | | enterprise zone |
Eli Lilly And Company | Eli Lilly | Pennsylvania | state | 2010 | $1,128,200 | | tax credit/rebate |
G.D. SEARLE & COMPANY | Pfizer | Missouri | state | 2002 | $1,126,728 | | tax credit/rebate |
Takeda Pharmaceuticals America, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2016 | $1,125,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2019 | $1,125,000 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2007 | $1,123,304 | | enterprise zone |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2004 | $1,120,000 | | grant |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2001 | $1,119,362 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2017 | $1,113,133 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | | enterprise zone |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2009 | $1,105,019 | | tax credit/rebate |
NOVARTIS | Novartis | New York | state | 2006 | $1,100,000 | | grant |
Dey Pharma, L.P., Mylan Inc. and Affiliates | Viatris | New Jersey | state | 2009 | $1,088,479 | | grant |
OSI Pharmaceuticals, Inc. | Astellas Pharma | New York | local | 2005 | $1,079,994 | | tax credit/rebate; property tax abatement |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $1,077,666 | | tax credit/rebate |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2020 | $1,076,396 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2020 | $1,065,000 | | tax credit/rebate |
PAREXEL International | Parexel International | Massachusetts | state | 2014 | $1,062,412 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2006 | $1,060,334 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2007 | $1,060,334 | | tax credit/rebate |
General Nutrition Corporation | Harbin Pharmaceutical Group | Indiana | state | 2014 | $1,050,000 | | tax credit/rebate |
Abiomed, Inc. | Johnson & Johnson | Massachusetts | state | 2016 | $1,050,000 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2016 | $1,045,614 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $1,038,094 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $1,031,751 | | tax credit/rebate |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2014 | $1,028,677 | | enterprise zone |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2015 | $1,026,957 | | tax credit/rebate |
Regeneron Warehouse Expansion | Regeneron Pharmaceuticals | New York | local | 2019 | $1,026,828 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2014 | $1,023,131 | | tax credit/rebate |
Synageva BioPharma | AstraZeneca | Massachusetts | state | 2014 | $1,021,550 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2016 | $1,013,383 | | tax credit/rebate |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,926 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,669 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,639 | | property tax abatement |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2017 | $1,008,259 | | tax credit/rebate |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2020 | $1,007,951 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2019 | $1,007,332 | | tax credit/rebate |
Fort Dodge Animal Health | Zoetis | Iowa | state | 2004 | $1,000,000 | | infrastructure assistance |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2005 | $1,000,000 | | tax credit/rebate |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $1,000,000 | | training reimbursement |
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | | $1,000,000 | | grant |
Novartis Pharmaceuticals Corp. | Novartis | California | state | 2014 | $1,000,000 | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2016 | $1,000,000 | | grant |
Pfizer, Inc. | Pfizer | Michigan | state | 2019 | $1,000,000 | | tax credit/rebate |
IDEXX DIstribution, Inc. | IDEXX Laboratories | Kentucky | state | 2019 | $1,000,000 | | tax credit/rebate |
Novavax, Inc. | Novavax Inc. | Maryland | local | 2020 | $1,000,000 | | grant/loan hybrid program |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2012 | $999,077 | | tax credit/rebate |
Ironwood Pharmaceuticals, Inc | Ironwood Pharmaceuticals | Massachusetts | state | 2011 | $996,605 | | tax credit/rebate |
Merck Animal Health | Merck | Louisiana | state | 2012 | $995,624 | | property tax abatement |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2015 | $992,077 | | tax credit/rebate |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2020 | $991,620 | | tax credit/rebate |
Forest Laboratories, Inc. and Forest Research | AbbVie | New Jersey | state | 2000 | $990,780 | | grant |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2015 | $985,000 | | tax credit/rebate |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | Pennsylvania | state | | $975,000 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2013 | $973,073 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2014 | $957,730 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2013 | $955,302 | | tax credit/rebate |
Silarx Pharmaceuticals, Inc. | Lannett Co. | New York | state | 2015 | $952,757 | | tax credit/rebate |